Feature Channels: Pharmaceuticals

Filters close

Not for public release

This news release is embargoed until 19-Apr-2024 9:00 AM EDT Released to reporters: 15-Apr-2024 12:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 19-Apr-2024 9:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Newswise: Metaphacts and Dimensions launch the Dimensions Knowledge Graph, powered by metaphactory
Released: 15-Apr-2024 11:45 AM EDT
Metaphacts and Dimensions launch the Dimensions Knowledge Graph, powered by metaphactory
Digital Science and Research Solutions Ltd

Digital Science solutions metaphacts and Dimensions announce the launch of the Dimensions Knowledge Graph, a large ready-made knowledge graph powering AI solutions in the pharmaceutical and life sciences industries.

     
Newswise: Beating Back Bitter Taste in Medicine: Monell Center Scientists Discover that Diabetes Drug is Partially Effective as a Bitter Blocker
Released: 9-Apr-2024 3:05 PM EDT
Beating Back Bitter Taste in Medicine: Monell Center Scientists Discover that Diabetes Drug is Partially Effective as a Bitter Blocker
Monell Chemical Senses Center

The bitter taste of certain drugs is a barrier to taking some medications as prescribed, especially for people who are particularly sensitive to bitter taste. A Monell team found that the diabetes drug rosiglitazone could partially block the bitter taste of some especially bad-tasting medications.

Newswise: Targeting vulnerability in B-cell development leads to novel drug combination for leukemia
Released: 8-Apr-2024 2:45 PM EDT
Targeting vulnerability in B-cell development leads to novel drug combination for leukemia
St. Jude Children's Research Hospital

Recent work by St. Jude Children’s Research Hospital scientists discovered which tumor cells resist treatment and why. By characterizing B-cells’ developmental stages, they designed and tested a drug combination to effectively treat resistant B-cell leukemia.

Newswise: How Scientists Are Accelerating Chemistry Discoveries With Automation
Released: 8-Apr-2024 11:00 AM EDT
How Scientists Are Accelerating Chemistry Discoveries With Automation
Lawrence Berkeley National Laboratory

Researchers have developed an automated workflow that could accelerate the discovery of new pharmaceutical drugs and other useful products. The new approach could enable real-time reaction analysis and identify new chemical-reaction products much faster than current laboratory methods.

Newswise:Video Embedded acetaminophen-may-be-less-heart-safe-than-previously-thought
VIDEO
1-Apr-2024 9:00 AM EDT
Acetaminophen May Be Less Heart-safe than Previously Thought
American Physiological Society (APS)

The common painkiller acetaminophen was found to alter proteins in the heart tissue when used regularly at moderate doses, according to a new study conducted in mice. Researchers will present their work this week at the American Physiology Summit in Long Beach, California.

Newswise: Rural pharmacists are pivotal to home-based palliative care
Released: 3-Apr-2024 11:05 PM EDT
Rural pharmacists are pivotal to home-based palliative care
University of South Australia

Pharmacists are being recognised for their vital role in supporting home-based rural palliative care patients, as new research shows that they not only enable patients to choose to stay at home, but also provide significant relief, comfort, and peace of mind for patients, carers, and family members.

24-Mar-2024 8:00 PM EDT
Rutgers Racing to Develop Paxlovid Replacement
Rutgers University-New Brunswick

SARS-CoV-2 will eventually become resistant to the only effective oral treatment. The world needs another.

Newswise: Liquid crystal nanoparticles supercharge antibiotics for cystic fibrosis
Released: 26-Mar-2024 5:00 PM EDT
Liquid crystal nanoparticles supercharge antibiotics for cystic fibrosis
University of South Australia

Cystic fibrosis is the most common, life-limiting genetic condition in Australia. It affects the lungs, digestive system, and reproductive system, producing excess mucus, infections, and blockages.

Released: 26-Mar-2024 3:05 PM EDT
Biotechnology CEO and Inventor of SiriusXM Satellite Radio Martine Rothblatt to Deliver Graduation Address to the University of Maryland School of Medicine’s 215th Graduating Class
University of Maryland School of Medicine

University of Maryland School of Medicine (UMSOM) Dean Mark T. Gladwin, MD, announced today that Martine Rothblatt PhD, JD, MBA, Chairperson and CEO of United Therapeutics, and inventor of SiriusXM Satellite Radio, will deliver the keynote address for this year’s graduating medical student class. The UMSOM MD graduation ceremony will take place at the Hippodrome Theatre on Thursday, May 16, 2024.

   

Not for public release

This news release is embargoed until 25-Mar-2024 5:00 PM EDT Released to reporters: 19-Mar-2024 2:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 25-Mar-2024 5:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 25-Mar-2024 12:35 PM EDT
Nucleus Genomics launches to bring whole-genome sequencing to the public
Nucleus Genomics

Nucleus Genomics, the next-generation genetic testing and analysis company, today announced the launch of its DNA analysis product to bring the benefits of personalized medicine to everyone.

Newswise: Breakthrough antibiotic shows promise against obstinate mycobacterial infections
Released: 25-Mar-2024 3:05 AM EDT
Breakthrough antibiotic shows promise against obstinate mycobacterial infections
National University of Singapore (NUS)

A team of scientists led by Prof Guillermo Bazan from NUS Institute for Functional Intelligent Materials (I-FIM) has developed a novel antibiotic named COE-PNH2 that is capable of combating hard-to-treat mycobacterial lung infections.

   
18-Mar-2024 9:00 AM EDT
New compound offers hope for deadly tropical disease
American Society for Biochemistry and Molecular Biology (ASBMB)

A newly developed compound is showing promise in animal studies as a more effective treatment for human schistosomiasis, an understudied tropical disease caused by parasitic worms.

18-Mar-2024 9:00 AM EDT
African catfish skin mucus yields promising antibacterial compound
American Society for Biochemistry and Molecular Biology (ASBMB)

Scientists report they have extracted a compound with powerful antibacterial properties from the skin of farmed African catfish.

Not for public release

This news release is embargoed until 22-Mar-2024 12:00 PM EDT Released to reporters: 20-Mar-2024 12:00 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Mar-2024 12:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

   
Newswise: Pharmacists using AI to help lower patient readmission rates
Released: 21-Mar-2024 11:00 AM EDT
Pharmacists using AI to help lower patient readmission rates
West Virginia University

An artificial intelligence tool West Virginia University health data scientists are developing could lessen medication errors that send recently discharged patients back to the hospital while reducing health care costs.

Released: 21-Mar-2024 9:05 AM EDT
Association for Diagnostics & Laboratory Medicine (formerly AACC) Submits Testimony to Congress Opposing FDA’s Proposed LDTs Rule
Association for Diagnostic and Laboratory Medicine (ADLM (formerly AACC))

“Today, we at the Association for Diagnostics & Laboratory Medicine (ADLM, formerly AACC) provided testimony to Congress regarding the impact of the Food and Drug Administration’s (FDA’s) proposed rule to impose FDA oversight on laboratory developed tests in addition to Centers for Medicare & Medicaid Services (CMS) oversight. While we share FDA’s goal of ensuring that laboratory developed tests are safe and effective, we have serious concerns about the agency’s proposal. If finalized, this rule would create a burdensome dual regulatory structure that would limit patient access to many life-saving tests.

Released: 21-Mar-2024 9:00 AM EDT
Kazia Therapeutics licenses paxalisib to Sovargen for intractable seizures in rare central nervous system diseases
Kazia Therapeutics Limited

Kazia Therapeutics Limited (NASDAQ: KZIA), a biotechnology company specialising in oncology, is pleased to announce that it has entered into an exclusive licensing agreement with Sovargen Co., Ltd, a biotechnology company specializing in central nervous system (CNS) diseases, to develop, manufacture and commercialise paxalisib as a potential treatment of intractable epilepsy in focal cortical dysplasia type 2 (FCD T2) and tuberous sclerosis complex (TSC) disease.

   
Released: 21-Mar-2024 7:05 AM EDT
ScienceMedia Welcomes Visionary Leaders to Advisory Board, Paving the Way for a New Era of Innovation
ScienceMedia

ScienceMedia, a global SaaS provider redefining the landscape of clinical mastery in the biotech and pharma industries, announces the formation of its inaugural advisory board.

Newswise: The Medical Minute: Vitamin supplements versus a balanced diet? No contest
Released: 20-Mar-2024 5:05 PM EDT
The Medical Minute: Vitamin supplements versus a balanced diet? No contest
Penn State Health

The use of vitamin supplements is on the rise in the U.S. But do they do any good? A Penn State Health expert talks about the benefits and pitfalls.

Released: 20-Mar-2024 4:05 PM EDT
Drug-pricing program improved prostate cancer treatment adherence
Michigan Medicine - University of Michigan

Prostate cancer patients receiving care at hospitals that are part of a special drug-pricing program were more likely to stick to their prescription drug therapy than patients at other hospitals, according to a study from researchers at the University of Michigan’s Rogel Cancer Center and Institute for Healthcare Policy and Innovation.

Newswise: PCOM and The Wistar Institute Announce Cancer Biology Graduate Program
Released: 20-Mar-2024 10:00 AM EDT
PCOM and The Wistar Institute Announce Cancer Biology Graduate Program
Philadelphia College of Osteopathic Medicine

The collaboration between Philadelphia College of Osteopathic Medicine (PCOM) and The Wistar Institute has resulted in the creation of a PhD program in Cancer Biology, preparing individuals for careers in cancer research and drug development.

   
Released: 19-Mar-2024 3:05 PM EDT
Targeting multiple COVID variants through the twist in the spike protein
University of Michigan

Teardrop-shaped particles designed to inactivate multiple strains of the SARS-CoV-2 virus could one day complement existing treatments for COVID-19, according to a new study led by researchers at the University of Michigan and Jiangnan University in Wuxi, China.

Newswise: Case Western Reserve University researchers report rise in global fungal drug-resistant infections
Released: 18-Mar-2024 9:00 AM EDT
Case Western Reserve University researchers report rise in global fungal drug-resistant infections
Case Western Reserve University

A global wave of infections caused by fungi growing drug-resistant has the medical community issuing precautions on how to protect yourself.

Not for public release

This news release is embargoed until 14-Mar-2024 2:00 PM EDT Released to reporters: 12-Mar-2024 12:05 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Mar-2024 2:00 PM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Not for public release

This news release is embargoed until 14-Mar-2024 11:05 AM EDT Released to reporters: 14-Mar-2024 11:05 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 14-Mar-2024 11:05 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 13-Mar-2024 3:05 PM EDT
Radyus Research Forges Strategic Partnership with Southern Research to Propel Life Sciences Commercialization
Radyus Research

Radyus Research partners with Southern Research for an innovative alliance in the development of new drugs.

   
Newswise: Cows to the rescue for diabetics? Transgenic cow produces human insulin in milk
Released: 13-Mar-2024 11:05 AM EDT
Cows to the rescue for diabetics? Transgenic cow produces human insulin in milk
College of Agricultural, Consumer and Environmental Sciences, University of Illinois Urbana-Champaign

An unassuming brown bovine from the south of Brazil has made history as the first transgenic cow capable of producing human insulin in her milk.

Newswise: What Makes a Pathogen Antibiotic-Resistant?
Released: 7-Mar-2024 9:00 AM EST
What Makes a Pathogen Antibiotic-Resistant?
Sanford Burnham Prebys

In a new study, Sanford Burnham Prebys researchers, led by Andrei L. Osterman, Ph.D., combined experimental evolution in a continuous culturing device with whole genome sequencing of evolving cultures to track how two bacterial pathogens acquired drug resistance against a pair of antibiotics, one long-used and the other experimental.

Newswise: Simmons Cancer Center awarded nearly $19 million in CPRIT funding
Released: 4-Mar-2024 11:05 AM EST
Simmons Cancer Center awarded nearly $19 million in CPRIT funding
UT Southwestern Medical Center

Nine scientists and physicians in the Harold C. Simmons Comprehensive Cancer Center at UT Southwestern Medical Center have been awarded nearly $13 million in grants from the Cancer Prevention and Research Institute of Texas (CPRIT) to support research and prevention efforts on a wide range of cancer issues. UTSW received another $6 million for recruitment efforts.

Released: 4-Mar-2024 8:05 AM EST
HIV Medication Can be Used Safely with Gender-Affirming Hormone Therapy
Thomas Jefferson University

New research shows HIV medications can be taken at the same time as hormone treatment without losing potency of either therapy.

Released: 29-Feb-2024 2:05 PM EST
Q&A: How a potential treatment for Alzheimer’s disease could also work for Type 2 diabetes
University of Washington

Alzheimer’s disease and Type 2 diabetes are part of a family of amyloid diseases that are characterized by having proteins that cluster together. University of Washington researchers have demonstrated more similarities between the two diseases.

Released: 28-Feb-2024 9:05 PM EST
In fight against brain pathogens, the eyes have it
Yale University

The eyes have been called the window to the brain. It turns out they also serve as an immunological barrier that protects the organ from pathogens and even tumors, Yale researchers have found.

Released: 28-Feb-2024 3:05 PM EST
How New Drug Approvals are Reshaping Treatment for Eosinophilic Esophagitis
University of North Carolina School of Medicine

The FDA has approved two medications for the treatment of eosinophilic esophagitis (EoE)—the first oral medication tailored for adults and the exclusive therapeutic option for children. Evan Dellon, MD, MPH, internationally known for his work with EoE, and colleagues continue to focus on optimizing usage for effective, personalized outcomes.

Newswise: Light stimulates a new twist for synthetic chemistry
27-Feb-2024 12:05 AM EST
Light stimulates a new twist for synthetic chemistry
Hokkaido University

Molecules that are induced by light to rotate bulky groups around central bonds could be developed into photo-activated bioactive systems, molecular switches, and more.

Released: 27-Feb-2024 8:05 PM EST
Five Cutting-edge Advances in Biomedical Engineering and Their Applications in Medicine
University of California San Diego

Bridging precision engineering and precision medicine to create personalized physiology avatars. Pursuing on-demand tissue and organ engineering for human health. Revolutionizing neuroscience by using AI to engineer advanced brain interface systems. Engineering the immune system for health and wellness. Designing and engineering genomes for organism repurposing and genomic perturbations.

Newswise: How gut bacteria become ‘persisters’ to avoid antibiotics
Released: 27-Feb-2024 1:05 PM EST
How gut bacteria become ‘persisters’ to avoid antibiotics
UT Southwestern Medical Center

A subpopulation of gut bacteria given a commonly used antibiotic became "persisters" that were able to survive without developing true resistance, UT Southwestern Medical Center scientists discovered. Their findings, published in Cell Host & Microbe, could lead to better ways to fight bacterial infections.

Newswise: ReadCube Expands Its Award-Winning Literature Management Platform with the Launch of Literature Review
Released: 27-Feb-2024 9:00 AM EST
ReadCube Expands Its Award-Winning Literature Management Platform with the Launch of Literature Review
Digital Science and Research Solutions Ltd

Digital Science is pleased to announce that ReadCube, an award-winning leader in literature management and full-text document delivery, has launched a new solution for research-driven organizations – known simply as Literature Review by ReadCube.

Replaces 807569

       
Newswise: ReadCube Expands Its Award-Winning Literature Management Platform with the Launch of Literature Review
Released: 27-Feb-2024 9:00 AM EST
ReadCube Expands Its Award-Winning Literature Management Platform with the Launch of Literature Review
Digital Science and Research Solutions Ltd

Digital Science is pleased to announce that ReadCube, an award-winning leader in literature management and full-text document delivery, has launched a new solution for research-driven organizations – known simply as Literature Review by ReadCube.

       
Newswise: RUDN doctors scanned medications through the packaging and inside the body
Released: 27-Feb-2024 4:05 AM EST
RUDN doctors scanned medications through the packaging and inside the body
Scientific Project Lomonosov

RUDN University doctors demonstrated the capabilities of a new method for remote analysis of drugs in packaging and after entering the body. They can be assessed using radio thermal emission of nanoparticles in drugs. Scientists were able to check the suitability of the medicine without opening the packaging or monitor it inside the body.

Newswise: Poison center calls for ‘magic mushrooms’ spiked after decriminalization, study finds
Released: 26-Feb-2024 9:05 PM EST
Poison center calls for ‘magic mushrooms’ spiked after decriminalization, study finds
University of Virginia Health System

Calls to U.S. poison centers involving psilocybin, or “magic mushrooms,” among adolescents and young adults rose sharply after several U.S. cities and states began decriminalizing the hallucinogen, University of Virginia School of Medicine researchers have found.

Newswise: Notre Dame develops user-friendly platform to access comprehensive nationwide opioid database
Released: 26-Feb-2024 1:05 PM EST
Notre Dame develops user-friendly platform to access comprehensive nationwide opioid database
University of Notre Dame

To provide a clear picture of opioid manufacture and travel, the University of Notre Dame developed a user-friendly interface to enable public access to more than 10 years of national controlled substance transaction information. This platform makes querying easier and faster, providing transactional data on 14 different opioids including fentanyl, hydrocodone and oxycodone.

   
Released: 22-Feb-2024 11:05 AM EST
Antidiabetic drugs could lower risk of primary and secondary brain cancer
University of Bristol

Diabetic patients who take anti-diabetic drugs - known as glitazones – long term had a lower risk of primary and secondary brain cancer compared with diabetic patients on other medications, new research led by the University of Bristol has found.

Released: 21-Feb-2024 2:05 PM EST
Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise
Newswise

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.

Released: 21-Feb-2024 11:00 AM EST
Mark Cuban Drug Company may offer savings for urology drugs
Wolters Kluwer Health: Lippincott

An online pharmacy offering standardized, transparent pricing can reduce out-of-pocket costs for patients taking common medications prescribed by urologists, suggests a study in the March issue of Urology Practice®, an Official Journal of the American Urological Association (AUA). The journal is published in the Lippincott portfolio by Wolters Kluwer.



close
2.57243